| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10309121 | Schizophrenia Research | 2015 | 11 Pages |
Abstract
Estrogens and SERMs could be effective augmentation strategies in the treatment of women with schizophrenia, although potential side effects, partially associated with longer duration use, should be taken into account. Future trials are needed to study long-term effects and effects on cognition.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Sophie M. Heringa, Marieke J.H. Begemann, Angelique J. Goverde, Iris E.C. Sommer,